tiprankstipranks
Heron Therapeutics Inc (HRTX)
:HRTX
US Market

Heron Therapeutics (HRTX) Financial Statements

Compare
1,567 Followers

Heron Therapeutics Financial Overview

Heron Therapeutics's market cap is currently $357.97M. The company's EPS TTM is $-0.089; its P/E ratio is ―; Heron Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 144.28M$ 127.04M$ 107.67M$ 86.35M$ 88.64M
Gross Profit$ 105.64M$ 61.94M$ 52.80M$ 40.33M$ 52.45M
Operating Income$ -11.53M$ -110.61M$ -174.66M$ -217.83M$ -228.16M
EBITDA$ -5.06M$ -103.79M$ -176.66M$ -215.25M$ -222.53M
Net Income$ -13.58M$ -110.56M$ -134.52M$ -217.66M$ -224.43M
Balance Sheet
Cash & Short-Term Investments$ 59.28M$ 80.41M$ 84.85M$ 157.58M$ 208.49M
Total Assets$ 233.15M$ 222.51M$ 250.95M$ 305.71M$ 353.56M
Total Debt$ 177.76M$ 179.63M$ 157.48M$ 159.50M$ 24.61M
Net Debt$ 151.96M$ 150.95M$ 142.11M$ 68.95M$ -80.53M
Total Liabilities$ 266.80M$ 256.48M$ 237.38M$ 228.14M$ 117.06M
Stockholders' Equity$ -33.65M$ -33.97M$ 13.57M$ 77.57M$ 236.49M
Cash Flow
Free Cash Flow$ -24.23M$ -60.33M$ -148.74M$ -206.38M$ -191.63M
Operating Cash Flow$ -22.53M$ -58.79M$ -146.91M$ -203.35M$ -184.82M
Investing Cash Flow$ 18.71M$ 18.00M$ -3.32M$ 32.73M$ 208.96M
Financing Cash Flow$ 940.00K$ 54.11M$ 75.06M$ 156.03M$ 9.11M
Currency in USD

Heron Therapeutics Earnings and Revenue History

Heron Therapeutics Debt to Assets

Heron Therapeutics Cash Flow

Heron Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis